Subthreshold Photocoagulation Using Endpoint Management in the PASCAL® System for Diffuse Diabetic Macular Edema

Table 2

Improvements over the study follow-up period.

Examination	Improved (%)	Unchanged (%)	Exacerbated (%)
BCVA	2 (20)	7 (70)	1 (10)
CMT	5 (50)	3 (30)	2 (20)
MV	2 (20)	8 (80)	0 (0)
MS	4 (40)	4 (40)	2 (20)

BCVA: best-corrected visual acuity; CMT: central macular thickness; MS: macular sensitivity; MV: macular volume.